CHTH · As filed with the SEC
CNL Healthcare Properties income statement, by fiscal year
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 | FY2017 Year ended Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenues: | ||||||||
| Rental income and tenant reimbursements | — | — | — | — | — | — | 34,971,000 | 149,516,000 |
| Resident fees and services | — | — | — | — | — | — | — | 248,900,000 |
| Rental income and related revenues | — | — | — | — | 26,287,000 | 33,547,000 | — | — |
| Rental income and related revenues | — | 26,920 | 26,862 | 30,101 | — | — | — | — |
| Rental income and related revenues | 27,298 | — | — | — | — | — | — | — |
| Resident fees and services | 338,662 | 314,560 | 295,799 | 265,321 | 280,854 | 288,344 | 276,623 | — |
| Total revenues | 365,960 | 341,480 | 322,661 | 295,422 | 307,141 | 321,891 | 311,594 | 398,416 |
| Operating expenses: | ||||||||
| Property operating expenses | 245,537 | 235,524 | 226,845 | 197,562 | 193,427 | 188,535 | 181,299 | 195,120 |
| General and administrative expenses | 8,759 | 9,101 | 10,209 | 9,116 | 9,413 | 13,158 | 12,839 | 13,010 |
| Asset management fees | — | — | — | — | — | — | — | 29,642,000 |
| Property management fees | — | — | — | — | — | — | — | 18,850,000 |
| Asset management fees | 13,353 | 13,856 | 14,074 | 15,733 | 18,051 | 18,298 | 18,389 | — |
| Property management fees | 16,712 | 15,438 | 14,703 | 12,981 | 13,772 | 12,840 | 14,075 | — |
| Financing coordination fees | — | — | — | — | — | 1,878,000 | — | 2,748,000 |
| Contingent purchase price consideration adjustments | — | — | — | — | — | — | — | 47,000 |
| Financing coordination fees | 0 | 2,671 | — | 0 | — | — | — | — |
| Impairment provision | — | 0 | 0 | 9,790 | 0 | 0 | 7,922 | — |
| Depreciation and amortization | 50,689 | 51,234 | 54,242 | 50,417 | 51,817 | 49,823 | 54,130 | 107,944 |
| Total operating expenses | 335,050 | 327,824 | 320,073 | 295,599 | 286,480 | 284,532 | 288,654 | 367,361 |
| Gain on sale of real estate | — | — | — | — | — | — | 1,049,000 | — |
| Gain on sale of real estate | 0 | 0 | 6,282 | 0 | 1,074 | 432 | — | — |
| Operating income | 30,910 | 13,656 | 8,870 | (177) | 21,735 | 37,791 | 23,989 | 31,055 |
| Other income (expense): | ||||||||
| Interest and other income | — | — | — | — | 5,655,000 | 1,531,000 | 335,000 | 60,000 |
| Interest and other income | 1,141 | 3,113 | 4,663 | 720 | — | — | — | — |
| Interest expense and loan cost amortization | (45,858) | (41,873) | (21,781) | (19,696) | (24,285) | (39,405) | (41,924) | (66,193) |
| Gain on change of control of a joint venture | 0 | 0 | 8,376 | — | — | — | — | — |
| Equity in earnings of unconsolidated entity | — | 0 | 0 | 471 | 1,050 | 731 | 489 | 403 |
| Nonoperating Income (Expense), Total | (44,717) | (38,760) | (8,742) | (18,505) | (17,580) | (37,143) | (41,100) | (65,730) |
| (Loss) income before income taxes | (13,807) | (25,104) | 128 | (18,682) | 4,155 | 648 | (17,111) | — |
| Income tax expense | (611) | (560) | (540) | (4,174) | (1,098) | (2,189) | (3,631) | 8,363 |
| Loss before gain on sale of real estate | — | — | — | — | — | — | — | (26,312,000) |
| Loss from continuing operations | — | (25,664) | (412) | (22,856) | 3,057 | (1,541) | (20,742) | — |
| Loss from discontinued operations | — | 0 | 0 | (10) | 954 | 353,337 | (4,409) | — |
| Net loss | (14,418) | (25,664) | (412) | (22,866) | 4,011 | 351,796 | (25,151) | (26,312) |
| Less: Net loss attributable to noncontrolling interest | — | — | — | — | — | — | — | (350,000) |
| Less: Amounts attributable to noncontrolling interests | 44 | 34 | 1,041 | 16 | 99 | 35 | (85) | — |
| Net income from discontinued operations | — | — | — | 0 | — | 265,000 | 6,000 | — |
| Net loss attributable to common stockholders | (14,462) | (25,698) | (1,453) | (22,882) | 3,912 | 351,496 | (25,072) | (25,962) |
| Net loss per share of common stock (basic and diluted) | — | — | — | — | — | — | — | (0.15) |
| Continuing operations | — | — | — | (0.13) | 0.01 | (0.01) | (0.12) | — |
| Discontinued operations | — | — | — | — | 0.01 | 2.03 | (0.03) | — |
| Weighted average number of shares of common stock outstanding (basic and diluted) | — | — | — | 173,960,000 | 173,960 | 173,963,000 | 174,247,000 | 175,151,000 |
| Distributions declared per share of common stock | — | — | — | — | — | — | — | 0.44 |
| Continuing operations, basic (in dollars per share) | — | (0.15) | (0.01) | — | — | — | — | — |
| Continuing operations, diluted (in dollars per share) | — | (0.15) | (0.01) | — | — | — | — | — |
| Discontinued operations, basic (in dollars per share) | — | 0.00 | 0.00 | — | — | — | — | — |
| Discontinued operations, diluted (in dollars per share) | — | 0.00 | 0.00 | — | — | — | — | — |
| Net loss per share of common stock, basic (in dollars per share) | (0.08) | — | — | — | — | — | — | — |
| Net loss per share of common stock, diluted (in dollars per share) | (0.08) | — | — | — | — | — | — | — |
| Weighted average number of shares of common stock outstanding, basic (in dollars per share) | 173,942 | 173,958 | 173,960 | — | — | — | — | — |
| Weighted average number of shares of common stock outstanding, diluted (in dollars per share) | 173,942 | 173,958 | 173,960 | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.